Publication | Closed Access
Specific enzyme inhibitors in vitamin biosynthesis. Part 3. The synthesis and inhibitory properties of some substrates and transition state analogues of riboflavin synthase
35
Citations
0
References
1980
Year
Vitamin BiosynthesisEnzymatic ModificationPharmaceutical ChemistryMedicinal ChemistryBiosynthesisDiversity Oriented SynthesisNatural Product BiosynthesisOxalate DerivativesInhibitory ActivitySpecific Enzyme InhibitorsBiochemistryDiversity-oriented SynthesisTransition State AnaloguesVitamin B ComplexDrug DevelopmentPharmacologyNatural Product SynthesisNatural SciencesPotential InhibitorsRiboflavin SynthaseMedicineDrug Discovery
Syntheses of potential inhibitors of riboflavin synthase are described. The tolerance of the enzyme to bulky substituents was investigated by the synthesis of substrate analogues which included lumazines and pyrido [2,3-d]-pyrimidines prepared by condensation of α-diketones and β-keto-aldehydes respectively with appropriate amino substituted uracils. Potential transition-state analogous, including 7-oxolumazines, 7-oxopyrido[2,3-d]pyrimidines, and 6,7-dioxolumaxines were also prepared by similar condensations using α-keto-acid derivatives, dimethyl acetylenedicarboxylate, and oxalate derivatives. Two possible dual affinity inhibitors were also prepared. The potential inhibitors were tested using riboflavin synthase from yeast or from E. coli, and their effectiveness is discussed in relation to the bulk and electronic character of the substituents.